Incidence of Phenotypic Aberrations in a Series of 467 Patients With B Chronic Lymphoproliferative Disorders: Basis for the Design of Specific Four-Color Stainings to Be Used for Minimal Residual Disease Investigation

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402584